BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34083030)

  • 41. A synergy of liquid chromatography with high-resolution mass spectrometry and coagulation test for determination of direct oral anticoagulants for clinical and toxicological purposes.
    Maier V; Slavík L; Ondra P
    Biomed Chromatogr; 2021 Oct; 35(10):e5195. PubMed ID: 34109658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measuring residual anti-Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa.
    Bourdin M; Perrotin D; Mathieu O; Herve T; Depasse F; Lu G; Conley PB; Contant G
    Int J Lab Hematol; 2021 Aug; 43(4):795-801. PubMed ID: 34092030
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Retrospective Review of Upper Gastrointestinal Bleed Outcomes During Hospital Admission While on Oral Anticoagulation.
    Scibelli N; Mangano A; Raynor K; Wilson S; Singh P
    Cureus; 2021 May; 13(5):e15061. PubMed ID: 34150404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative effectiveness and safety of edoxaban versus warfarin in patients with atrial fibrillation: A nationwide cohort study.
    Nielsen PB; Søgaard M; Jensen M; Ording AG; Lip GY
    Int J Stroke; 2022 Jun; 17(5):536-544. PubMed ID: 34142600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electronic monitoring of adherence to once-daily and twice-daily direct oral anticoagulants in patients with atrial fibrillation: Baseline data from the SMAAP-AF trial.
    Shiga T; Kimura T; Fukushima N; Yoshiyama Y; Iwade K; Mori F; Ajiro Y; Haruta S; Yamada Y; Sawada E; Hagiwara N;
    J Arrhythm; 2021 Jun; 37(3):616-625. PubMed ID: 34141014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Venous Thromboembolic Prophylaxis After Total Hip and Knee Arthroplasty.
    Lieberman JR; Bell JA
    J Bone Joint Surg Am; 2021 Aug; 103(16):1556-1564. PubMed ID: 34133395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness and safety of oral anticoagulation treatment beyond 1 year after venous thromboembolism in patients at intermediate recurrence risk.
    Johnsen SP; Rasmussen TB; Falstie-Jensen AM; Harboe L; Stynes G; Dybro L; Hansen ML; Brandes A; Grove EL; Münster AM
    Basic Clin Pharmacol Toxicol; 2021 Sep; 129(3):210-220. PubMed ID: 34128322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct oral anticoagulant use in special populations.
    Lamarche MC; Alrajhi E; Wells PS
    Curr Opin Pulm Med; 2021 Sep; 27(5):311-318. PubMed ID: 34115699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks.
    Atterman A; Friberg L; Asplund K; Engdahl J
    TH Open; 2021 Apr; 5(2):e176-e182. PubMed ID: 34104856
    [No Abstract]   [Full Text] [Related]  

  • 50. Improved efficacy/safety profile of factor XIa inhibitor BMS-724296 versus factor Xa inhibitor apixaban and thrombin inhibitor dabigatran in cynomolgus monkeys.
    Wong PC; Quan ML
    Res Pract Thromb Haemost; 2021 May; 5(4):e12524. PubMed ID: 34095733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus.
    Kido K; Ghaffar YA; Lee JC; Bianco C; Shimizu M; Shiga T; Hashiguchi M
    PLoS One; 2021; 16(6):e0252549. PubMed ID: 34086768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies.
    van den Ham HA; Souverein PC; Klungel OH; Platt RW; Ernst P; Dell'Aniello S; Schmiedl S; Grave B; Rottenkolber M; Huerta C; Martín Merino E; León-Muñoz LM; Montero D; Andersen M; Aakjaer M; De Bruin ML; Gardarsdottir H
    Pharmacoepidemiol Drug Saf; 2021 Oct; 30(10):1339-1352. PubMed ID: 34173286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of Low-Dose Direct Acting Anticoagulant and Warfarin in patients Aged ≥80 years With Atrial Fibrillation.
    Chaudhry UA; Ezekowitz MD; Gracely EJ; George WT; Wolfe CM; Harper G; Harper GR
    Am J Cardiol; 2021 Aug; 152():69-77. PubMed ID: 34162485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Impact of Rivaroxaban and Apixaban on Tacrolimus Trough Levels.
    Scheibner AC; Franco-Martinez C; Kincaide E; Hall R; Long C
    Prog Transplant; 2021 Sep; 31(3):236-241. PubMed ID: 34155947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apixaban in Patients with Atrial Fibrillation and Severe Renal Dysfunction: Findings from a National Registry.
    Elis A; Klempfner R; Gurevitz C; Gilady E; Goldenberg I
    Isr Med Assoc J; 2021 Jun; 23(6):353-358. PubMed ID: 34155848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monotherapy Anticoagulation to Expedite Home Treatment of Patients Diagnosed With Venous Thromboembolism in the Emergency Department: A Pragmatic Effectiveness Trial.
    Kline JA; Adler DH; Alanis N; Bledsoe JR; Courtney DM; d'Etienne JP; Diercks DB; Garrett JS; Jones AE; Mackenzie DC; Madsen T; Matuskowitz AJ; Mumma BE; Nordenholz KE; Pagenhardt J; Runyon MS; Stubblefield WB; Willoughby CB
    Circ Cardiovasc Qual Outcomes; 2021 Jul; 14(7):e007600. PubMed ID: 34148351
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of sinus rhythm 6 weeks after cardioversion of atrial fibrillation: a pre-planned post hoc analysis of the X-VeRT trial.
    Cappato R; Ezekowitz MD; Hohnloser SH; Meng IL; Wosnitza M; Camm AAJ;
    Europace; 2021 Oct; 23(10):1539-1547. PubMed ID: 34128075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of a commercially available DOAC absorbent on two integrated procedures for lupus anticoagulant detection.
    Tripodi A; Scalambrino E; Chantarangkul V; Paoletti O; Clerici M; Novembrino C; Boscolo-Anzoletti M; Peyvandi F; Testa S
    Thromb Res; 2021 Aug; 204():32-39. PubMed ID: 34126321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination.
    FACME multidisciplinary working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination
    Neurologia (Engl Ed); 2021; 36(6):451-461. PubMed ID: 34112621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety of Direct Oral Anticoagulants Compared to Warfarin for Atrial Fibrillation after Cardiac Surgery: A Systematic Review and Meta-Analysis.
    Hage A; Dolan DP; Nasr VG; Castelo-Branco L; Motta-Calderon D; Ghandour H; Hage F; Papatheodorou S; Chu MWA
    Semin Thorac Cardiovasc Surg; 2022; 34(3):947-957. PubMed ID: 34111554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.